(BLCO) Bausch + Lomb - Ratings and Ratios

Bausch + Lomb Corporation is a global eye health company with operations in over 20 countries, including the United States, China, Japan, Germany, the United Kingdom, Canada, and others. The company operates through three key business segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment offers a comprehensive range of contact lenses, including daily disposable and frequently replaced options, as well as therapeutic contact lenses for optical correction during healing. Additionally, this segment provides contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops for conditions such as eye allergies, conjunctivitis, dry eye, and redness relief.

The Pharmaceuticals segment focuses on developing and marketing both proprietary and generic pharmaceutical products. These products are used for post-operative treatments, as well as for managing conditions such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical devices, consumables, and technologies for treating cataracts, corneal, vitreous, and retinal eye conditions. This includes intraocular lenses, delivery systems, phacoemulsification equipment, and other surgical instruments used in cataract surgery.

Bausch + Lomb sells its products and services through a combination of direct sales forces and independent distributors. Founded in 1853, the company is headquartered in Vaughan, Canada, and operates as a subsidiary of Bausch Health Companies Inc. Its website can be accessed at https://www.bausch.com.